Master Protocols: FDA New Flexible Approach in Cancer Trials
Master Protocols (MPs) mark a significant evolution in the realm of clinical research, especially notable in oncology. These protocols,...
Discovering DCTs: an Insider’s Perspective
In this discussion, we journey into the evolving realm of decentralized clinical trials (DCTs), with insights from Owen McCarthy,...
Exploring New Complexities of DCTs: Insights from Japan
DIA Japan convened a cadre of industry professionals passionate about the burgeoning realm of Decentralized Clinical Trials (DCTs). As...
Decentralized Clinical Trials: Big Pharma’s New Frontier
In a recent webinar, industry luminaries including Harpreet Gill from ICON plc, Jane Twitchen from Biogen, Angela May from...
Clinical Trial Patient Engagement and Experience Data: Why It’s Vital
A significant shift towards prioritizing clinical trial patient engagement (PE) and patient experience data (PXD) is palpable in clinical...
The Rise of The “Metasite” in Decentralized Clinical Trials
Decentralized clinical trials are at a pivotal juncture, shaped by technological advancements and evolving regulatory landscapes. While traditional clinical...
How to Make Clinical Trials for Elderly with Disabilities More Inclusive
The global demographic is undergoing a significant shift, with an increasing number of elderly patients. This aging population brings...
How to Bolster Clinical Operations in the Post-COVID-19 Pandemic World
Clinical Operations, the backbone of the clinical trials sector, has been impacted by the COVID-19 pandemic. Post-pandemic, many clinical...
Reducing Patient Burden in Clinical Trials: How to Make Trials More Feasible for Patients
In the realm of medical advancements, there’s a growing concern that’s capturing the attention of the clinical research community:...